Abstract
A new series of substituted benzo[h]chromene, benzochromenopyrimidine, and benzochromenotriazolopyrimidine derivatives were synthesized via chemical transformations of iminonitrile, ethoxymethylene amino, and cyanomethylene functionalities. The chemical structures of the synthesized compounds were assured by spectroscopic data and elemental analysis. The larvicidal efficacy of these compounds against Culex pipiens L. larvae was investigated, revealing potent insecticidal activity, particularly for compounds 6, 10, and 16, exceeding that of the standard insecticide chlorpyrifos. The mode of action of these compounds was explored through molecular docking studies, indicating their potential as acetylcholine esterase (AChE) inhibitors and nicotinic acetylcholine receptors (nAChR) blockers. The structure–activity relationship analysis highlighted the influence of substituents and fused heterocyclic rings on larvicidal potency. These findings suggest that the synthesized compounds hold promise as potential candidates for developing novel and effective mosquito control agents.
Keywords: Benzo[h]chromene, Benzochromenopyrimidine, Benzochromenotriazolopyrimidine, Culex pipiens, Disease vector, Larvicidal efficacy
Subject terms: Biochemistry, Chemistry
Introduction
Benzochromene derivatives have demonstrated a wide range of biological activities, including antimicrobial, antioxidant, anti-inflammatory, analgesic, anti-proliferative, and anti-tubercular properties1–7. Among these, benzochromenopyrimidines are particularly interesting due to their antimicrobial, analgesic, anti-inflammatory, and anticancer effects8–13. Notably, some benzochromenopyrimidine derivatives act as acetylcholinesterase inhibitors, potent antioxidants used in Alzheimer's disease treatment, and antidyslipidemic agents14,15. Additionally, 1,2,4-triazolopyrimidines, a type of hybrid heterocycle, have displayed antitumor, antimicrobial, and antiviral activities16–19.
Culex pipiens, a globally distributed mosquito species, poses a significant public health threat as a vector for various arboviruses, including West Nile, Saint Louis encephalitis, Eastern equine encephalitis, and Usutu viruses20–23. Additionally, it transmits filariasis and avian malaria, and recent studies suggest it may contaminate raw milk with harmful microbial pathogens20,24. The ability of C. pipiens to transmit various diseases to both humans and animals, coupled with its widespread distribution and increasing resistance to conventional insecticides, underscores the importance of developing new and effective control strategies to mitigate its impact on public health and agriculture20,25.
The escalating issue of insecticide resistance in disease vectors, such as C. pipiens, necessitates the urgent development and evaluation of novel insecticidal compounds to overcome this challenge25. The exploration of heterocyclic compounds, including pyrano[2,3-c]pyrazoles, as a source of novel insecticides has shown promise, as demonstrated by El-Sayed et al. (2023)26, who reported the larvicidal activity of these derivatives against C. pipiens and Musca domestica. This highlights the potential of heterocyclic compounds, such as benzochromenes, as a promising avenue for developing effective insecticidal agents. Previous studies have shown that some benzochromenopyrimidine derivatives act as acetylcholinesterase inhibitors14, further supporting the rationale for investigating the insecticidal potential of benzochromenes and their derivatives.
Insecticides are classified based on how they work, including nerve poisons, growth regulators, chitin synthesis inhibitors, and juvenile hormone mimics27. Nerve poisons disrupt the insect's nervous system through various mechanisms. One group of nerve poisons are acetylcholinesterase (AChE) inhibitors. These insecticides, such as the organophosphate chlorpyrifos, prevent the breakdown of the neurotransmitter acetylcholine, leading to its buildup and overstimulation of the nervous system28,29. Neonicotinoids, like nitenpyram, target nicotinic acetylcholine receptors (nAChRs), causing prolonged activation and ultimately paralysis30,31. Another class of nerve poisons includes pyrethroids and indoxacarb. These insecticides disrupt voltage-gated sodium channels (VGSCs), which are crucial for nerve signal transmission32. This disruption leads to hyperexcitation of nerve cells, eventual paralysis, and ultimately insect death27.
Building upon our previous research on the synthesis of heterocyclic systems with biological applications11,12,26,33–38, we report the synthesis of fused benzochromene, benzochromenotriazolopyrimidine, and benzochromenopyrimidine systems. The primary objective of this study is to investigate the insecticidal potential of these compounds against C. pipiens immatures. A molecular docking analysis will complement the larvicidal bioassay to elucidate the potential mode of action of these compounds, contributing to our understanding of any resulting toxicity in the biological assay.
Results and discussion
Chemistry
In our running study, the intended starting compounds 2-amino-4-aryl-4H-benzo[h]chromene-3-carbonitrile 1a, b were formerly synthesized via a multi-component reaction of malononitrile, 2-chlorobenzaldehyde (or 4-chlorobenzaldehyde) and α-naphthol in ethanol containing a catalytic amount of piperidine (Scheme 1). The structures of 1a and 1b were inferred from m.p and typical IR data with those reported in the literature39,40.
Scheme 1.
Treatment of β-enaminonitrile 1a, b with some carbon electrophiles.
The functionalities in β-enaminonitrile 1a,b rendered it a beneficial precursor for the creation of new heterocyclic compounds. Thus, refluxing β-enaminonitrile 1a,b with some appointed carbon electrophiles such as acetic anhydride and/or chloroacetyl chloride afforded pyrimidinone derivatives 2 and/or 3, respectively (Scheme 1). The IR, 1H-NMR, and 13C-NMR spectra as well as the elemental analyses were completely in accord with those assigned structures. (cf. experimental).
The behavior of the understudy enaminonitrile 1a towards acetyl chloride was investigated (Scheme 1), it was reported that the treatment of enaminonitrile with acid chloride afforded either acetamide derivative41 or pyrimidinone derivative42, but herein none of the expected structures have been isolated. The isolated product was identified as 7-(2-chlorophenyl)-10-methyl-7H,11H-dihydro-7H,8H-benzo7,8 chromeno[2,3-d][1,3]oxazin-8-one (4). The IR spectrum of 4 revealed the absence of an absorption band of the nitrile group and the presence of an absorption band at 1732, and 1656 cm−1 attributed to C=O of oxazinone and C=N groups, respectively. Moreover, the 13C-NMR spectrum of 4 exhibited signals for the carbonyl group and C2 of the oxazinone ring.
Moreover, condensation of enaminonitrile 1a, b with triethyl orthoformate yielded the corresponding ethyl formimidate 5a, b (Scheme 1), which was subsequently exploited as the principal intermediate for the synthesis of novel chromenopyrimidines and chromenotriazolopyrimidines via reaction with diverse nitrogen nucleophiles. The 1H-NMR spectrum of 5a, b showed the presence of triplet and quartet signals referring to the existence of protons of an ethoxy group. The 1H-NMR spectrum of 5a showed its presence as two diastereomers syn and anti isomers with predominant of anti-isomer due to the presence of H-bonding is shown (Fig. 1).
Figure 1.

Two diastereomeric isomers of compound 5a.
Aminolysis of the formimidate 5a with heteroamines either 2-furanylmethanamine or 2-aminopyridine in boiling dioxane yielded the formamidine derivatives 6 and 7, respectively (Scheme 2). The evidence for the uncyclized structures 6 and 7, was deduced from the IR spectrum which showed an absorption band at 2191 cm-1 corresponding to (C≡N) in addition to the appearance of singlet signals for NH proton exchangeable with D2O in 1H-NMR spectra.
Scheme 2.
Reaction of ethyl formimidate 5a with heteroamines.
Meanwhile, the reactivity of ethyl formimidate 5a with hydrazine hydrate and some hydrazine derivatives has been reported (Scheme 3). So, stirring ethyl formimidate 5a with excess hydrazine hydrate for 10 h at room temperature yielded the amino-imino derivative 8. The structure of 8 was established from spectral data. The IR spectrum of 8 showed the disappearance of νC≡N in addition to the appearance of νNH, νNH2, and νC=N at 3337, 3319, 3285, and 1653 cm−1, respectively. Moreover, appearance of two singlet signals for NH, NH2 exchangeable with D2O besides a singlet signal at δ 8.25 ppm for C2 pyrimidine-H in addition to the disappearance of the triplet and quartet signals attributed to the ethyl protons of its precursor 5a in 1H-NMR (DMSO-d6) spectrum reinforces the proposed structure.
Scheme 3.
Reaction of formimidate 5a, b with hydrazine hydrate and some hydrazine derivatives.
The uncyclized product, 1[{4-(2-chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-ylimino}-methyl]thiosemicarbazide 9 was obtained as brown crystals on conducting ethyl formimidate 5a with thiosemicarbazide in dioxane. Likewise, condensation of compound 5a with 2-hydroxy-benzohydrazide in dioxane gave benzo[h]chromene benzohydrazide derivative 10. (Scheme 3) Moreover, when formimidate derivatives 5a, b were allowed to react with p-toluene sulphonohydrazide in refluxing dioxane, benzo[7,8]chromeno[2,3-d]pyrimidine derivatives 11a,b were afforded. (Scheme 3).
On the other hand, it has been mentioned that ethyl formimidate derivatives reacted with acid hydrazides through two-ring annulations to give fused triazolopyrimidine systems43,44. Thus, triazolo[1,5-c]pyrimidine derivatives 12 and 13 were isolated via the treatment of ethyl formimidate 5b, 5a with benzoylhydrazide and 2-cyanoacetic acid hydrazide in refluxing dioxane (Scheme 3). A supportive clue for the suggested structure 12 was upcoming from its IR spectrum as it lacked absorption bands for both cyano-, carbonyl, and NH groups and showed only absorption bands for CH-Ar at 3046 cm−1 and C=N at 1619 cm-1. Moreover, the spectral data were utilized to deduce the structure of 13 and showed its existence in two tautomeric forms (Fig. 2). Thus, the IR spectrum displayed absorption bands for νNH, νC≡N, and νC=N at 3340, 2261(small), 2192, 1658, and 1627 cm−1, respectively. Strong support for structure 13 was forthcoming from its 1H-NMR (DMSO-d6) spectrum which disclosed the disappearance of the triplet and quartet signals assigned to the ethyl protons of its precursor 5a and showed the appearance of signals at δ(ppm): 3.58 (s, 2H, CH2CN), 4.39 (s, 1H, NH, exchangeable with D2O), 5.40 (s, 1H, C4-pyran), 6.27 (s, 1H, =CH), 6.98–8.23 (m, 10H, Ar–H), 9.73 (s, 1H, pyrimidine-H).
Figure 2.

Two isomeric forms of compound 13.
The reactivity of cyanomethyl functionality towards aromatic aldehydes as electrophilic reagents has been investigated by many researchers to insert and construct new heterocyclic systems and it was found to give generally Knoevenagel condensation product under basic conditions and yielded either 2-iminochromene45,46 or 2-chromenones47 in case of salicylaldehyde. Thus, the reaction of cyanomethyl derivative 13 with p-methoxybenzaldehyde and/or salicylaldehyde in refluxing dioxane in the presence of a catalytic amount of piperidine afforded arylidene derivative 14 and chromenone derivative 15, respectively (Scheme 4). 1H-NMR (DMSO‐d6) spectrum of 14 disclosed the disappearance of any bands for CH2-group of its precursor 13 and displayed bands at δ(ppm): 3.83 (s, 3H, OCH3), 6.24 (s, 1H, C4-pyran), 7.08–7.93 (m, 13H, Ar–H), 8.30 (m, 1H, Ar–H), 9.69 (s, 1H, pyrimidine-H) in addition to a new singlet band at δ 8.15 ppm due to the presence of benzylidene CH.
Scheme 4.
Reaction of cyanomethyl derivative 13 with aromatic aldehydes and diazonium salt.
On the other hand, the elimination of the 2-iminochromene structure and the preference of the 2-chromenone structure for compound 15 were deduced from spectral data. Thus, the IR spectrum of 15 revealed the absence of stretching bands for the C≡N or NH groups, and the presence of a stretching band at 1747 cm−1 attributed to an oxo-coumarin group. Strong evidence for the structure 15 came from 1H-NMR (DMSO‐d6) which lacked the existence of either methylene protons of its precursor 13 or any signal attributed to NH proton and showed bands at δ(ppm): 6.32 (s, 1H, C4-pyran), 7.01–8.34 (m, 14H, Ar–H), 8.63 (s, 1H, chromenone ring), 8.31 (d, 1H, Ar–H), 9.77 (s, 1H, pyrimidine-H).
Meanwhile, the reactivity of cyanomethyl functionality towards diazonium salts as nitrogen electrophilic reagents was also studied. Thus, treatment of cyanomethyl derivative 13 with 2-hydroxy-benzenediazonium chloride in the presence of sodium acetate at − 5 °C yielded the hydrazonyl derivative 16. Adequate evidence for the chemical structure of 16 was substantiated by the correct elemental analysis and spectral data.
Biological evaluation
Larvicidal activity
Given the reported activity of benzochromenopyrimidine derivatives as acetylcholinesterase (AChE) inhibitors14 and pyranopyrazole derivatives as potent insecticidal nicotinic acetylcholine receptor (nAChR) activators26, we evaluated fifteen synthesized benzochromene, benzochromenotriazolopyrimidine, and benzochromenopyrimidine derivatives against C. pipiens larvae as potential neurotoxic insecticides.
In our study, all fifteen tested compounds demonstrated insecticidal activity (Table 1) against the third larval instar of the C. pipiens lab strain, inducing neurotoxic symptoms such as tremors, uncoordinated movements, paralysis, and finally larvae death. This observation underscores the potential action of these compounds as nerve poisons that may act on the neural receptors (AChE, nAChRs, or VGSC α subunit) of mosquito larvae. Notably, all compounds were more potent than the standard insecticide Chlorpyrifos under identical experimental conditions, supporting the hypothesis of their action as neurotoxic insecticides. Chlorpyrifos was chosen as a reference compound due to its widespread use as a conventional insecticide and its known activity as an acetylcholinesterase inhibitor. While it may not share structural similarities with the synthesized compounds, it provides a benchmark for comparing the larvicidal potency of the novel compounds.
Table 1.
The average insecticidal activity for 15 tested compounds against the third larval instar of C. pipiens after 12 h. compared to the insecticidal activity of a conventional insecticide “Chlorpyrifos” at the same conditions. Confidence Interval (C.I) of 95%.
| Compound No | LC25/ mg/mL ± SD | LC50/ mg/mL ± SD | LC90/ mg/mL ± SD | χ2cal./tab. (7.8) | r2 | P value | Toxicity index |
|---|---|---|---|---|---|---|---|
| 1a | 169.2 ± 0.6 | 334.3 ± 0.1 | 1219.4 ± 0.22 | 2.4 | 0.87 | 0 | 23.3 |
| 1b | 220.9 ± 0.4 | 361.8 ± 0.2 | 923.1 ± 0.26 | 1.1 | 0.94 | 0.009 | 21.5 |
| 3 | 217.7 ± 0.9 | 378.8 ± 0.12 | 1084.7 ± 0.14 | 0.9 | 0.99 | 0.008 | 20.5 |
| 5a | 190.1 ± 0.75 | 342.7 ± 0.3 | 1050.1 ± 0.15 | 2.8 | 0.99 | 0.004 | 22.7 |
| 5b | 108.3 ± 0.8 | 182.1 ± 0.42 | 488.4 ± 0.24 | 1.6 | 0.93 | 0.001 | 42.8 |
| 6 | 42.3 ± 0.2 | 78.0 ± 0.32 | 252.0 ± 0.36 | 1.5 | 0.99 | 0.006 | 100 |
| 7 | 77.2 ± 0.1 | 183.5 ± 0.4 | 950.2 ± 0.6 | 5.4 | 0.99 | 0.009 | 42.5 |
| 8 | 101.9 ± 0.95 | 191.6 ± 0.65 | 635.8 ± 0.29 | 1.4 | 0.92 | 0.001 | 40.7 |
| 9 | 88.9 ± 0.7 | 175.0 ± 0.25 | 633.7 ± 0.24 | 4.6 | 0.95 | 0.001 | 44.5 |
| 10 | 88.4 ± 0.5 | 139.9 ± 0.23 | 221.2 ± 0.61 | 4.1 | 0.95 | 0.002 | 55.7 |
| 11b | 179.4 ± 0.6 | 308.8 ± 0.26 | 866.8 ± 0.68 | 3.6 | 0.87 | 0 | 25.2 |
| 12 | 112.1 ± 0.8 | 186.9 ± 0.34 | 649.9 ± 0.69 | 2.2 | 0.95 | 0 | 41.7 |
| 13 | 200.5 ± 0.65 | 386.1 ± 0.24 | 1341.4 ± 0.45 | 0.7 | 0.99 | 0.008 | 20.2 |
| 14 | 246.4 ± 0.1 | 357.8 ± 0.47 | 727.1 ± 0.25 | 1.8 | 0.97 | 0.002 | 21.7 |
| 16 | 80.2 ± 0.12 | 127.5 ± 0.36 | 307.2 ± 0.69 | 4.5 | 0.98 | 0.002 | 61.1 |
| Chlorpyrifos | 247.3 ± 0.31 | 588.3 ± 0.28 | 3052.4 ± 0.95 | 1.1 | 0.99 | 0.007 | 13.2 |
(LC (mg/L)) Lethal Concentration/ milligram per Litre.
(χ2cal./tab.) Chi-square value calculated/tabulated.
(r2) Correlation coefficient.
Compound 6 exhibited the highest larvicidal activity (LC50 = 78.0 ± 0.32 mg/L), followed by compounds 16 (LC50 = 127.5 ± 0.36 mg/L) and 10 (LC50 = 139.9 ± 0.23 mg/L). Compounds 9, 5b, 7, 12, and 8 demonstrated moderate and convergent LC50 values, showing slightly lower potency compared to compound 6. Compounds 11b, 1a, 5a, 14, 1b, 3, and 13 displayed convergent LC50 values, indicating the lowest larvicidal activity among the tested compounds. Nevertheless, all compounds outperformed Chlorpyrifos in terms of LC50 values (Table 1).
The toxicity index (TI), a key indicator of insecticidal potency, varied among the compounds. Compound 6 showed the highest TI value (100), while compound 13 exhibited the lowest (20.2). Chlorpyrifos had the lowest TI value (13.2) under the same conditions. The goodness of fit test confirmed the validity of the LDP line for all tested compounds, indicating the reliability of the results (Table 1). Finally, in control experiments, the larvae were exposed to the same concentrations (100 to 1000 mg/mL) of DMF solvent in water. Using the Abbott formula, which was employed to account for control mortality, the toxicity of DMF in water was under 5% which indicates low activity.
Molecular docking assessment
Molecular docking studies were conducted to investigate the potential mode of action for the tested compounds on different neural receptors, and the resulting data was largely promising in identifying the potential neural targets that may lead to insect death. To study the binding interactions of the synthesized potential insecticides with mosquito neuroreceptors, three-dimensional (3D) structures of C. pipiens acetylcholinesterase (AChE), nicotinic acetylcholine receptor (nAChRs), and voltage-gated sodium channel binding protein alpha subunit (VGSC α subunit) were modeled using protein homology modeling, as they were not available in the Protein Data Bank (PDB). The AChE model was based on the crystal structure of Anopheles gambiae acetylcholinesterase in complex with PMSF (SMTL ID: 5ydj.1), while AlphaFold DB models of Q9W3G6.1.A Nicotinic acetylcholine receptor alpha3 and SCNA_DROME (gene: para) from Drosophila melanogaster were used for nAChRs and VGSC α subunit, respectively. These templates offered high query coverage (99%, 99%, and 98%) and good sequence identity (83.88%, 70.85%, and 87.04%) with the target C. pipiens proteins28,48. The quality of the AChE model was assessed using various parameters, including GMQE score (0.84), QMEAN Z-score (-0.53), and Ramachandran plot analysis (94.50% favored residues and 0.47% outliers), indicating good structural reliability and stability (Fig. 3)28,48.
Figure 3.
Quality estimate parameters for modeled C. pipiens acetylcholine esterase (AChE) protein (a) Modelled AChE 3D structure (b) Local model quality estimate (c) Ramachandran plot (d) Comparison with a non-redundant set of PDB structures.
The molecular docking results revealed that all tested compounds exhibited favorable binding affinities (negative S scores) to the three target receptors (AChE, nAChRs, and VGSC α subunit), indicating potential interactions and supporting the observed larvicidal activity and neurotoxic symptoms in C. pipiens larvae. Notably, the most potent compounds (6, 10, and 16), which exhibited the lowest lethal concentrations (LC50) in larvicidal assays, consistently demonstrated the strongest binding affinities to both AChE and nAChRs. For instance, compound 6 displayed S scores of − 8.11 kcal/mol for AChE and − 6.27 kcal/mol for nAChRs (Table 2), forming an H-acceptor interaction with ASP 200 (B), H-pi interactions with TRP 408 (B), and pi-H interactions with PHE 416 (B) in the AChE active site (Fig. 4), and an H-acceptor interaction with ARG 107 (A) in the nAChRs active site (Fig. 5). Compound 10 displayed S scores of − 8.33 kcal/mol for AChE and − 6.74 kcal/mol for nAChRs (Table 2), forming an H-donor interaction with GLU 415 (B) and pi-H interactions with TYR 249 (B) in the AChE active site (Fig. 4), and an H-donor interaction with LEU 38 (A) and pi-H interactions with ASP 109 (A) in the nAChRs active site (Fig. 5). Compound 16 displayed S scores of − 8.28 kcal/mol for AChE and − 6.79 kcal/mol for nAChRs (Table 2), forming H-acceptor interactions with PHE 457 (B) and pi-H interactions with TYR 461 (B) in the AChE active site (Fig. 4), and H-donor and H-acceptor interactions with ILE 105 (A) and ARG 107 (A), respectively, in the nAChRs active site (Fig. 5). These values were significantly lower (more negative) than those of the reference compounds chlorpyrifos (S = − 6.89 kcal/mol for AChE, forming H-acceptor interactions with TRP 212 (B) and GLY 246 (B), and H-pi interactions with TRP 212 (B)) and nitenpyram (S = − 6.04 kcal/mol for nAChRs, forming H-donor and H-acceptor interactions with ILE 110 (A) and GLN 78 (A), respectively, and pi-H interactions with VAL 122 (A)) (Table 2 & Fig. 6). In addition to the neurotoxic effects observed in the biological assay, the in silico docking analysis revealed a stronger binding affinity of the novel compounds to AChE and nAChRs compared to chlorpyrifos and nitenpyram. This was evidenced by the formation of more hydrogen bonds with the active site gorge of these receptors and is consistent with their higher docking scores relative to the conventional insecticides. These findings support the hypothesis that the insecticidal activity of the novel compounds is primarily mediated through interactions with AChE, although nAChRs could also contribute to their neurotoxic effects. Furthermore, the analysis of connection types, residues connected, and the number of bonds predicted to be formed in all tested compounds compared to Chlorpyrifos and Nitenpyram further strengthens the hypothesis that these targets are involved in the mode of action of the novel compounds (S File 1).
Table 2.
In silico docking analysis of binding affinity and pose fitness between novel annulated Benzo[h]chromenes and C. pipiens neural targets (AChE, nAChRs, and VGSC α subunit).
| Compd | AChE | nAChRs | VGSC α subunit | |||
|---|---|---|---|---|---|---|
| *S | **RMSD Refine | S | RMSD Refine | S | RMSD Refine | |
| 1a | − 6.73 | 1.85 | − 5.55 | 1.61 | − 5.99 | 0.98 |
| 1b | − 6.63 | 1.11 | − 5.65 | 0.83 | − 5.30 | 1.34 |
| 3 | − 6.86 | 1.94 | − 5.99 | 1.14 | − 6.04 | 1.69 |
| 5a | − 6.64 | 1.76 | − 5.91 | 1.51 | − 5.83 | 1.90 |
| 5b | − 7.15 | 1.08 | − 6.19 | 1.56 | − 5.66 | 0.85 |
| 6 | − 8.11 | 1.31 | − 6.27 | 1.20 | − 6.42 | 1.81 |
| 7 | − 7.40 | 1.01 | − 6.67 | 1.35 | − 6.18 | 1.73 |
| 8 | − 6.61 | 1.41 | − 5.48 | 1.19 | − 5.49 | 1.32 |
| 9 | − 7.25 | 1.32 | − 6.44 | 1.06 | − 6.09 | 1.14 |
| 10 | − 8.33 | 1.61 | − 6.74 | 1.34 | − 6.28 | 1.62 |
| 11b | − 8.01 | 1.89 | − 7.10 | 1.52 | − 6.74 | 1.90 |
| 12 | − 7.90 | 1.12 | − 5.88 | 1.39 | − 6.24 | 1.55 |
| 13 | − 7.88 | 1.66 | − 6.04 | 0.72 | − 6.20 | 1.64 |
| 14 | − 7.60 | 1.80 | − 6.40 | 1.72 | − 6.74 | 0.77 |
| 16 | − 8.28 | 1.50 | − 6.79 | 1.64 | − 6.56 | 1.00 |
| Reference insecticide | Chlorpyrifos | Nitenpyram | Indoxacarb | |||
| − 6.89 | 1.27 | − 6.04 | 1.78 | − 6.61 | 1.55 | |
*S: Docking Score, kcal/mol.
**RMSD: Root mean square deviation, Å.
Figure 4.
2D&3D molecular interactions of the compounds 6, 10, and 16 with AChE of C. pipiens. These 3 compounds showed the highest toxicity against C.pipiens larvae.
Figure 5.
2D&3D molecular interactions of the compounds 6, 10, and 16 with nAChRs of C. pipiens. These 3 compounds showed the highest toxicity against C.pipiens larvae.
Figure 6.
D&3D molecular interactions of the conventional acetylcholine esterase inhibitor, Chlorpyrifos with AChE of C. pipiens. and The conventional neonicotinoid, Nitenpyram with nAChRs of C. pipiens.
Interestingly, compounds with higher LC50 values generally exhibited weaker binding affinities to both AChE and nAChRs compared to compounds 6, 10, and 16. This observation further reinforces the hypothesis that AChE and nAChRs are the primary targets for these compounds, with binding affinity playing a significant role in their insecticidal efficacy and the severity of neurotoxic symptoms induced in C. pipiens larvae. However, the relationship between binding affinity and insecticidal activity was not always straightforward. Some compounds, such as 11b and 13, showed a relatively strong binding affinity to AChE (-8.01 and -7.88 kcal/mol, respectively) despite having moderate LC50 values. This suggests that factors other than binding affinity, such as pharmacokinetics or the specific interactions within the binding pocket, may also influence the insecticidal activity and the resulting neurotoxic effects of these compounds. Furthermore, compounds 11b and 14 exhibited good binding affinity to VGSC α subunit (S = − 6.74 kcal/mol), comparable to the reference compound indoxacarb (S = − 6.61 kcal/mol). Compound 11b formed H-donor and ionic interactions with GLU 1405 (A) and LYS 1104 (A), respectively, while compound 14 formed H-donor and H-acceptor interactions with GLU 161 (A) and GLY 1109 (A), respectively. Indoxacarb formed an H-donor bond with GLU 1405 (A). This suggests that VGSC α subunit may also be a potential secondary target for these compounds.
Overall, the molecular docking results provide valuable insights into the potential mode of action of these novel benzochromene derivatives and their observed neurotoxic effects on C. pipiens larvae. The strong correlation between insecticidal activity, neurotoxicity, and binding affinity to AChE and nAChRs suggests that these receptors are the primary targets for most of these compounds, with AChE likely being the more important target due to the stronger correlation between binding affinity and insecticidal activity. However, the results also indicate that VGSC α subunit may be a potential secondary target for some compounds and that factors beyond binding affinity can modulate insecticidal activity and neurotoxicity. It is important to note that this is a theoretical explanation based on docking studies, and further studies, including in vitro enzyme inhibition assays and in vivo assays, are needed to confirm these hypotheses and to elucidate the precise mechanisms by which these compounds interact with the receptors and exert their insecticidal and neurotoxic effects.
Structure–activity relationship (SAR) study
The larvicidal efficacy of synthesized benzo[h]chromene derivatives against Culex pipiens larvae is significantly influenced by the interplay between structural modifications and their resulting interactions with multiple neural targets. Specifically, the nature of substituents on the benzo[h]chromene scaffold and the type of fused heterocyclic ring play pivotal roles.The presence of various functional groups, including halogens, aromatic rings, sulfur, and nitrogen-containing moieties, not only modulates interactions with these neural targets but also impacts other toxicological aspects. These include absorption, lipophilicity, bioavailability, and the potential for metabolic resistance within the insect.49,50 These functional groups can engage in specific interactions with amino acid residues within target receptors, utilizing mechanisms such as hydrogen bonding, pi-pi stacking, or ionic interactions. Such interactions can lead to neurotoxic effects, culminating in the death of mosquito larvae. These diverse factors collectively contribute to the observed variations in insecticidal activity among the tested compounds. The interaction with neural targets, particularly acetylcholinesterase (AChE), emerges as a key factor in the toxicity of these derivatives. The higher binding affinity to AChE compared to other neural receptors suggests that AChE inhibition is a primary mechanism of action. The specific orientation and electronic nature of functional groups, whether electron-withdrawing or donating, can influence the strength and specificity of these interactions. Furthermore, structural modifications can affect steric hindrance or electron density distribution, thereby altering the interaction of the tested compounds with the target receptor and, consequently, its toxicity. This can lead to either increased or decreased insecticidal activity, as observed across all tested compounds51–53.
The precursor compounds, 2-amino-4-aryl-4H-benzo[h]chromene-3-carbonitriles (1a, 1b), displayed comparatively lower larvicidal activity than most of their derivatives. This suggests that while the 2-amino and 3-cyano groups may contribute to insecticidal properties, their presence alone does not confer optimal potency against C. pipiens larvae. Molecular docking analysis corroborates this observation, revealing that 1a and 1b primarily interact with AChE through a single hydrogen bond between the cyano group (N37) and ASP200, along with pi-H interactions between the benzo[h]chromene scaffold and aromatic residues (TRP408 and PHE416) in the enzyme largest pocket. Notably, the docking scores for 1a and 1b are higher than those of the more potent compounds 6, 10, and 16, indicating a potential correlation between lower AChE binding affinity and lower larvicidal efficacy noticed for 1a and 1b.
Acetylation and subsequent cyclization of 1b yielded compound 3, which showed a slight decrease in insecticidal activity compared to 1b. This decrease can be attributed to the loss of the cyano-ASP200 hydrogen bond interaction, present in 1b, and the formation of a new, potentially less favorable, hydrogen bond between CL 32 and ILE198 in the AChE active site in 3. Additionally, 1b formed a pi-H interaction with PHE416 that was not observed in 3.
Condensation of enaminonitriles 1a and 1b with triethyl orthoformate yielded the corresponding ethyl formimidates 5a and 5b, respectively. Notably, 5b exhibited a significant increase in larvicidal activity compared to its parent compound 1b, while 5a did not exhibit a significant increase in activity compared to 1a. The docking scores (S) of 1b and 5b are − 6.63 and − 7.15 kcal/mol, respectively. This indicates that 5b binds more strongly to AChE than 1b. The increased binding affinity of 5b could be due to the ethyl formimidate group being less bulky than the amino group in 1b, reducing steric hindrance and allowing for a more favorable interaction with the AChE active site. Additionally, the ethyl formimidate group may form favorable interactions with other residues in the active site, further increasing the binding affinity of 5b. These factors could contribute to the increased larvicidal activity of 5b compared to 1b.
Aminolysis of 5a with heteroamines led to the replacement of the ethoxy group (–OCH2CH3) with a formamidine group, containing a nitrogen atom that can act as a hydrogen bond donor. This structural modification resulted in the formation of compounds 6 and 7, which exhibited enhanced larvicidal activity compared to 5a. The increase in potency can be attributed to the formation of a stronger hydrogen bond between the cyano group (CN) at the 2-position and ASP200 in the AChE active site. The docking scores of 6 and 7 (− 8.11 and − 7.40 kcal/mol, respectively) are lower (more negative) than those of 5a (− 6.64 kcal/mol), indicating stronger binding affinity to AChE. The additional H-pi interaction observed between the furan ring of 6 and TRP408 may further enhance its binding affinity and inhibitory activity compared to 7.
Further modifications of 5a led to the synthesis of hydrazinolysis products (8, 9, 10,11b) and chromenotriazolopyrimidine derivatives (12,13), which exhibited moderate larvicidal activity. The moderate activity of these compounds suggests that while the modifications introduced new interactions with AChE, they may not have been as optimal as the interactions observed in the most potent compounds. For example, compound 8 formed a hydrogen bond with ILE198, similar to compound 3, but lacked the additional interactions observed in compounds 6, 10, and 16. Compound 9 formed a hydrogen bond with SER250, a residue not involved in the interactions of the most potent compounds, suggesting that this interaction may not be as crucial for larvicidal activity. Among the hydrazinolysis products, compound 10 stood out due to its ability to form a strong hydrogen bond with GLU415, a key residue in the AChE active site, contributing to its higher potency compared to other derivatives in this group. This interaction with GLU415 was unique to compound 10 and may explain its increased activity.
Compound 16 a hydrazonyl derivative of 13, displayed the second-highest larvicidal activity, likely due to its ability to form multiple hydrogen bonds (with PHE457 and TYR461) and hydrophobic interactions with key residues in the AChE active site gorge. The presence of the hydrazonyl moiety in 16 may have introduced these additional interactions, contributing to its enhanced binding affinity and inhibitory activity compared to other triazolopyrimidine derivatives.
Interestingly, the triazolopyrimidine derivatives (12, 13, and 14) interacted with AChE through pi-H and H-pi interactions, which were not observed in the hydrazinolysis products. This suggests that the triazolopyrimidine ring system may be involved in different interactions with AChE compared to the hydrazinolysis products, potentially influencing their larvicidal activity. Additionally, the presence of a phenyl group in compound 12 may have contributed to its higher activity compared to 13 and 14 due to additional hydrophobic interactions. However, although compound 12 does not show a hydrogen bond formed with AChE its potent toxicity may be related to its interactions with nAChRs and VGSC α subunit since it forms ILE 105 (A) H-donor with nAChRs and GLU 160 (A) H-acceptor with VGSC α subunit.
While the cyano (CN) group plays a major role in the interaction of potent compounds with the ASP200 residue of acetylcholinesterase (AChE) in C. pipiens (S. File 1), the exact composition of the catalytic triad in this species remains to be elucidated. In most vertebrates, AChE inhibition typically involves interactions with the serine, histidine, and glutamic acid residues of the established catalytic triad54. However, due to potential species-specific variations in AChE structure, it is crucial to identify the corresponding catalytic triad residues in C. pipiens to fully understand the mechanism of AChE inhibition by these compounds. This will provide valuable insights into the selectivity and specificity of these larvicides, contributing to the development of more targeted and effective mosquito control strategies.
While molecular docking offers valuable insights into structure–activity relationships (SAR), it is inherently limited by its static nature and inability to fully capture the dynamic interplay between ligands and proteins, as well as the influence of solvent effects. Consequently, docking scores may not always accurately reflect experimental binding affinities55. To address these limitations and enhance our understanding of SAR, incorporating molecular dynamics (MD) simulations and free energy calculations can provide a more comprehensive and dynamic perspective on compound-target interactions. MD simulations can reveal conformational changes, induced fit effects, and the role of water molecules in ligand binding, while free energy calculations can offer more accurate estimates of binding affinities56.
In addition, further in vitro investigations into the precise mechanisms of interaction between benzo[h]chromene derivatives and their target receptors, including AChE, as well as the resulting insecticidal and neurotoxic effects, remain a crucial avenue for future research. This will not only deepen our understanding of the molecular basis of their larvicidal activity but also aid in the rational design of more effective and selective compounds for mosquito control.
Experimental
Chemistry
All melting points were measured on a Griffin and George melting-point apparatus (Griffin & Georgy Ltd., Wembley, Middlesex, UK) and are uncorrected. IR spectra were recorded on the Pye Unicam SP1200 spectrophotometer (Pye Unicam Ltd., Cambridge, UK) by using the KBr wafer technique. 1H-NMR spectra were determined on a Varian Gemini 300 MHz on Bruker Avance III using tetramethylsilane as an internal standard (chemical shifts in δ scale), while 13C NMR spectra were run at 75 MHz. EI-MS was measured on a Shimadzu GC–MS (Columbia, MD) operating at 70 eV. Elemental analyses were carried out at the Microanalytical Unit, Faculty of Science, Ain Shams University, using a Perkin-Elmer 2400 CHN elemental analyzer (Waltham, MA), and satisfactory analytical data (± 0.4) were obtained for all compounds. The homogeneity of the synthesized compounds was controlled by thin layer chromatography (TLC), using aluminum sheet silica gel F254 (Merck).
2-Amino-4-(2-chlorophenyl)-4H-benzo[h]chromene-3-carbonitrile 1a and 2-amino-4-(4-chlorophenyl)-4H-benzo[h]chromene-3-carbonitrile 1b
Typical reaction procedure for the synthesis of naphthopyrane (multi-component step): 1-naphthol (5 g, 3.4 mmol) was mixed with malononitrile (1.88 mL, 3.4 mmol), o-chlorobenzaldehyde and/or p-chlorobenzaldehyde (3.8 mL, 3.4 mmol) in (50 mL) absolute ethanol containing piperidine (2 mL). The mixture was allowed to reflux for about 7 h. The obtained solid was filtered off and washed with ethanol then recrystallized from dioxane to give 1a and 1b, respectively.
1a: brown crystals, yield: 91%, m.p. 239–240 0C (Lit. m.p. 238–240)39.
1b: pale yellow crystals, yield: 86%, m.p. 234–235 0C (Lit. m.p. 230–232)39,40.
7-(2-Chlorophenyl)-10-methyl-7,9-dihydro-8H-benzo-[7,8]chromeno[2,3-d]pyrimidin-8-one 2
A solution of enaminonitrile 1a (1 g, 3 mmol) in acetic anhydride (20 mL) was heated under reflux for 12 h. The formed solid while reflux was filtered off, dried, and then crystallized from dioxane to give 2 as buff crystals; yield: 55%, m.p. > 300 oC. IR (KBr, cm-−1): 3156 (NH), 1655 (C=O). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 2.34 (s, 3H, CH3), 5.70 (s, 1H, C4-pyran), 7.17–7.65 (m, 8H, Ar–H), 7.86 (d, 1H, Ar–H, J = 8.1 Hz), 8.23 (d, 1H, Ar–H, J = 8.1 Hz), 12.50 (s, 1H, NH, exchangeable with D2O). 13C-NMR (DMSO-d6) δ (ppm): 20.97, 35.85, 98.81, 117.78, 120.75, 123.07, 124.41, 125.63, 126.87, 126.93, 127.65, 127.71, 128.29, 129.51, 130.96, 131.88, 132.81, 142.66, 143.40, 159.01, 161.55, 162.18. MS (m/z, %): 376 (M+. + 2, 29.7%), 374 (M+., 25.71%), 217 (100%), 110 (36.12%), 72 (83.97%) Anal. Calc. for C22H15ClN2O2 (374.84): C, 70.50; H, 4.03; Cl, 9.46; N, 7.47. Found: C, 70.58; H, 4.13; Cl, 9.26; N, 7.56.
10-(Chloromethyl)-7-(4-chlorophenyl)-7,9-dihydro-8H-benzo[7,8]chromeno[2,3-d]pyrimidin-8-one 3
A solution of enaminonitrile 1b (1 g, 3 mmol) and chloroacetyl chloride (0.23 mL, 3 mmol) in dioxane (15 mL) was heated under reflux for 6 h. The reaction mixture was cooled and then poured into ice-cold water. The obtained solid was filtrated off and crystallized from benzene to give 3 as pale-yellow crystals; yield: 74%, m.p: 294–295 oC. IR (KBr, cm-1): 3320 (br, NH), 2959, 2851(CH alph.), 1657 (C=O), 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 4.54 (s, 2H, CH2), 5.32 (s, 1H, C4-pyran), 7.25–7.67 (m, 8H, Ar–H), 7.90 (d, 1H, Ar–H, J = 7.8 Hz), 8.26 (d, 1H, Ar–H, J = 8.1 Hz), 13.02 (br s, 1H, NH, exchangeable with D2O). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 38.02, 42.13, 101.69, 118.23, 120.68, 123.05, 124.65, 126.51, 126.90, 126.98, 127.76, 128.38, 128.80, 129.42, 129.89, 131.28, 132.83, 143.54, 143.97, 156.61, 161.05, 162.09. MS (m/z, %): 411 (M+. + 2, 15.44%), 409 (M+., 18.22%), 36 (35.09%), 295 (100%), 161 (74.94%), 149 (48.47%), 106 (73.54%), 75 (43.53%). Anal. Calc. for C22H14Cl2N2O2 (409.27): C, 64.56; H, 3.45; Cl, 17.32; N, 6.84. Found: C, 64.65; H, 3.49; Cl, 17.22; N, 6.90.
7-(2-Chlorophenyl)-10-methyl-7H,8H-benzo[7,8]chromeno[2,3-d] [1,3]oxazin-8-one 4
A solution of enaminonitrile 1a (1 g, 3 mmol) in acetyl chloride (20 mL) was refluxed for 18 h on a water bath. The excess solvent was evaporated and the solid formed was crystallized from benzene to give 4 as brown crystals; yield: 53%, m.p. 225–228 0C. IR (KBr, cm−1): 1732 (C = O), 1656 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 2.59 (s, 3H, CH3), 5.92 (s, 1H, C4-pyran), 7.18–7.89 (m, 9H, Ar–H), 8.26 (d, 1H, Ar–H, J = 8.4 Hz). 13C-NMR (DMSO-d6) δ (ppm): 24.97, 38.65, 111.38, 117.11, 120.68, 122.85, 124.90, 125.25, 127.25, 127.79, 128.10, 128.30, 129.17, 129.88, 131.89, 132.97, 140.97, 160.26, 167.08. MS (m/z, %): 377 (M+. + 2, 7.87%), 375 (M+., 12.56%), 261(100%), 218 (56.87), 179 (47.61%), 143 (90.03%), 133 (50.17%). Anal. Calc. for C22H14ClN2O3 (375.81): C, 70.31; H, 3.75; Cl, 9.43; N, 3.73. Found: C, 70.23; H, 3.91; Cl, 9.54; N, 3.81.
Ethyl N-[4-(2-chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-yl] formimidate 5a and Ethyl N-[4-(4-chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-yl] formimidate 5b
A solution of enaminonitrile 1a or 1b (1 g, 3 mmol) in triethylorthoformate (20 mL) was heated under reflux for 8 h. The reaction solution was evaporated till dryness. The obtained solid was filtrated off and crystallized from ethanol to give 5a and 5b, respectively.
5a: yellow crystals; yield: 79%, m.p. 177–179 0C. IR (KBr, cm-1): 2207 (C≡N), 1656 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 1.21 (Syn), 1.36 (Anti) (2t, 3H, CH2CH3, J = 6.9 Hz), 4.13 (Syn), 4.38 (Anti) (2q, 2H, CH2CH3, J = 6.9 Hz), 5.63 (s, 1H, C4-pyran), 6.97 (d, 1H, Ar–H, J = 8.7 Hz), 7.30–7.65 (m, 7H, Ar–H), 7.88 (d, 1H, Ar–H, J = 9 Hz), 8.36 (d, 1H, Ar–H, J = 7.2 Hz), 8.18 (Syn), 8.94 (Anti) (2 s, 1H, N = CH). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 13.92, 18.57, 54.01, 78.75, 115.37, 117.63, 121.32, 122.83, 124.93, 125.24, 127.04, 127.15, 127.65, 128.15, 129.50, 130.01, 131.82, 132.28, 133.01, 140.50, 143.12, 157.72, 161.92. MS (m/z, %): 390 (M+. + 2, 16.04%), 388 (M+., 23.09%), 375 (72%), 349 (52.68%), 254 (48.50%), 247 (100%), 245 (61.71%), 232 (63.75%), 204 (92.47%), 161 (43.96%), 134 (30.74%) Anal. Calc. for C23H17ClN2O2 (388.85): C, 71.04; H, 4.41; Cl, 9.12; N, 7.20. Found: C, 71.20; H, 4.50; Cl, 9.26; N, 7.11.
5b: pale brown crystals; yield: 73%, m.p: 170–171 0C. IR (KBr, cm−1): 2205 (C≡N), 1654 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 1.36 (t, 3H, CH2CH3, J = 6.9 Hz), 4.42 (q, 2H, CH2CH3, J = 6.9 Hz), 5.22 (s, 1H, C4-pyran), 7.07 (d, 1H, Ar–H, J = 8.4 Hz), 7.34–7.67 (m, 7H, Ar–H), 7.89 (d, 1H, Ar–H, J = 8.4 Hz), 8.36 (d, 1H, Ar–H, J = 7.5 Hz), 8.94 (s, 1H, N=CH). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 13.92, 41.23, 63.99, 79.80, 116.06, 117.89, 121.31, 122.92, 124.84, 125.94, 127.05, 127.13, 127.66, 128.92, 130.13, 132.17, 132.95, 142.86, 142.99, 157.43, 162.01. MS (m/z, %): 390 (M+. + 2, 7.51%), 388 (M+., 10.95%), 380 (53.96%), 328 (62.27%), 286 (62.44%), 273 (61.03%), 147 (100%). Anal. Calc. for C23H17ClN2O2 (388.85): C, 71.04; H, 4.41; Cl, 9.12; N, 7.20. Found: C, 71.13; H, 4.21; Cl, 9.18; N, 7.04.
N'-{4-(2-Chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-yl}-N-(furan-2-ylmethyl) formimidamide 6
A solution of 5a (1 g, 2.5 mmol) in dioxane (15 mL) and 2-furanylmethanamine (0.22 mL, 2.5 mmol) was refluxed for 12 h. The reaction mixture was cooled and then poured onto ice-cold water. The obtained solid was filtrated off and crystallized from benzene to give 6 as yellow crystals, yield: 82%, m.p. 138–139 0C. IR (KBr, cm-1): 3432 (NH), 2191 (C≡N), 1657 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 5.40 (s, 1H, C4-pyran), 5.83 (s, 2H, CH2), 6.13 (s, 1H, NH exchangeable with D2O), 6.29 (d, 1H, furan ring), 6.97–8.31 (m, 12H, 10Ar-H + 2H furan ring), 8.33 (s, 1H, N=CH). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 36.69, 37.93, 95.36, 106.08, 110.31, 116.7, 120.73, 122.64, 123.02, 124.01, 125.4, 126.73, 126.88, 126.94, 127.23, 127.71, 127.92, 128.17, 128.84, 129.29, 129.78, 130.14, 130.37, 131.19, 131.76, 131.95,132.81, 132.93, 140.09, 142.06, 142.18, 143.84, 152, 156.69, 160.36, 160.48, 162.08 . MS (m/z, %): 441 (M+. + 2, 24.71%), 439 (M+., 18.37%), 330 (100%), 234 (60.20%), 295 (90.28%), 165(32.71%), 122 (49.68%), 65 (34.37%) Anal. Calc. for C26H18ClN3O2 (439.90): C, 70.99; H, 4.12; Cl, 8.06; N, 9.55. Found: C, 70.85; H, 4.30; Cl, 8.26; N, 9.44.
N'-{4-(2-Chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-yl}-N-(pyridin-2-yl) formamidine 7
A solution of 5a (1 g, 2.5 mmol) in dioxane (15 mL) and 2-aminopyridine (0.24 mL, 2.5 mmol) was refluxed for 24 h. The reaction mixture was cooled and then poured onto ice-cold water. The obtained solid was filtrated off and crystallized from ethanol to give 7 as pale-yellow crystals, yield: 65%, m.p. 222–224 0C. IR (KBr, cm−1): 3397 (NH), 2191 (C≡N), 1644 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 6.27 (s, 1H, C4-pyran), 7.00–7.91 (m, 11H, 8H Ar–H + 3H pyridine), 8.09–8.12 (m, 2H, C6-pyridine moiety + NH exchangeable with D2O), 8.26–8.33 (m, 2H, Ar–H), 8.57 (s, 1H, N = CH). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 36.39, 98.74, 113.66, 116.92, 118.70, 120.78, 122.97, 124.39, 125.56, 127.07, 127.78, 127.96, 128.29, 129.55, 130.39, 131.57, 131.79,132.97, 137.99, 140.41, 143.43, 148.00, 151.90, 156.59, 157.93, 162.85. MS (m/z, %): 439 (M+. + 2, 1.54%), 437 (M+., 10.89%), 404 (42.40), 394 (38.26%), 360 (30.35%), 254 (35.13%), 105 (100%), 94 (38.17%). Anal. Calc. for C26H17ClN4O (436.90): C, 71.48; H, 3.92; Cl, 8.11; N, 12.82. Found: C, 71.60; H, 3.82; Cl, 8.29; N, 12.88.
7-(2-Chlorophenyl)-8-imino-7H-benzo[7,8]chromeno[2,3-d]-pyrimidin-9(8H)-amine 8
A solution of 5a (1 g, 2.5 mmol) in excess hydrazine hydrate (3 mL) was stirred at room temperature for 10 h. The formed solid was filtered off, dried, and crystallized from toluene to give 8 as pale brown crystals, yield: 70%, m.p: 202–205 0C. IR (KBr, cm−1): 3336, 3319, 3284, 3180 (NH, NH2), 1652 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 5.74 (s, 2H, NH2 exchangeable with D2O), 5.79 (s, 1H, C4-pyran), 6.80 (br.s, 1H, NH exchangeable with D2O), 7.18–7.67 (m, 8H, Ar–H), 7.88 (d, 1H, Ar–H, J = 8.1 Hz), 8.23 (s, H, Ar–H), 8.25 (s, 1H, pyrimidine-H). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 37.21, 97.38, 116.91, 120.77, 122.98, 124.39, 125.50, 126.91, 127.73, 127.97, 128.83, 129.78, 131.10, 131.98, 132.85, 141.42, 143.29, 151.22, 155.04, 156.74. MS (m/z, %): 376 (M+. + 2, 27.86%), 374 (M+., 28.40%), 353 (95.12%), 347 (82.94%), 342 (100%), 287 (47.04%), 207 (61.97%). Anal. Calc. for C21H15ClN4O (374.83): C, 67.29; H, 4.03; Cl, 9.46; N, 14.95. Found: C, 67.14; H, 4.23; Cl, 9.52; N, 15.07.
1-[{4-(2-Chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-ylimino} methyl]thiosemicarbazide 9
A mixture of iminoether derivative 5a (1 g, 2.5 mmol) and thiosemicarbazide (0.23 g, 2.5 mmol) in dioxane (20 mL) was heated under reflux for 15 h. The formed solid while reflux was filtered off, dried, and then crystallized from ethanol to give 9 as brown crystals, yield: 73%, m.p. 256–259 °C. IR (KBr, cm−1): 3467, 3308, 3155 (NH2, 2NH), 2191 (CN), 1645 (C = N), 1261 (C=S). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 5.76 (s, 1H, C4-pyran), 6.35 (s, 1H, NH exchangeable with D2O), 6.98–7.41 (m, 7H, 5Ar-H + NH2 exchangeable with D2O), 7.54–7.74 (m, 3H, 3Ar-H + NH exchangeable with D2O), 7.87 (d, 1H, Ar–H, J = 8.1 Hz), 8.23 (s, 1H, N = CH), 8.29 (d, 1H, Ar–H, J = 8.1 Hz). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 37.04, 94.48, 116.95, 120.85, 123.06, 123.94, 125.74, 126.85, 126.92, 127.71, 127.94, 129.23, 130.34, 131.76, 131.95, 132.92, 140.26, 143.95, 156.90, 162.41, 162.72. MS (m/z, %): 435 (M+. + 2, 20.23%), 433 (M+., 35.18%), 412 (63.51), 399 (54.78%), 383 (50.44%), 334 (66.04%), 320 (70.40%), 303 (88.43%), 242 (56.11%), 198 (63.63%), 191 (74.85%), 168 (74.94%), 164 (100%), 120 (48.24%), 118 (82.67%), 112 (89.93%), 110 (84.68%), 92 (56.39%), 87 (42.86%), 72 (54.82%). Anal. Calc. for C22H16ClN5OS (433.91): C, 60.90; H, 3.72; Cl, 8.17; N, 16.14; S, 7.39. Found: C, 60.98; H, 3.57; Cl, 8.07; N, 16.32; S, 7.31.
N'-{[(4-(2-Chlorophenyl)-3-cyano-4H-benzo[h]chromen-2-ylimino]methyl}-2-hydroxybenzo hydrazide 10
A mixture of imnioether 5a (1 g, 2.5 mmol) and salicylhydrazide (0.39 g, 2.5 mmol) in dioxane (15 mL) was heated under reflux for 20 h. The reaction mixture was cooled and then poured onto ice-cold water. The obtained solid was filtrated off then boiled with petroleum ether and then crystallized from benzene to give 10 as pale brown crystals, yield: 75%, m.p. 253–256 °C. IR (KBr, cm-1): br. 3184 (NH, OH), 2192 (C≡N), 1660 (C=O). 1H-NMR (DMSO-d6) (δ ppm): 6.27 (s, 2H, C4-pyran + NH exchangeable with D2O), 6.94–8.34 (m, 15H, 14Ar-H + NH exchangeable with D2O), 9.74 (s, 1H, N = CH), 10.92 (s, 1H, OH, exchangeable with D2O). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 37.13, 38.21, 54.85, 114.96, 116.61, 117.30, 119.30, 119.31,119.77, 120.22, 120.28, 120.78, 121.63, 122.68, 124.14, 125.49, 126.82, 126.97, 127.29, 128.03,128.86, 128.94, 129.29, 129.43, 129.56, 129.69, 129.86, 131.26, 132.03, 132.86, 133.12, 133.52, 134.15, 136.57, 140.91, 142.22, 157.67, 158.54, 160.41, 165.80. MS (m/z, %): 496 (M+. + 2, 8.20%), 494 (M+., 10.73%), 314 (19.84%), 289 (100%), 252 (48.07%), 194 (34.89%), 139 (41.68%). Anal. Calc. for C28H19ClN4O3 (494.94): C, 67.95; H, 3.87; Cl, 7.16; N, 11.32. Found: C, 67.75; H, 3.95; Cl, 7.20; N, 11.18.
N-{7-(2-Chlorophenyl)-8-imino-7H-benzo[7,8]chromeno[2,3-d]-pyrimidin-9(8H)-yl}-4-methylbenzenesulfonamide 11a and N-[7-(4-Chlorophenyl)-8-imino-7H-benzo[7,8]chromeno[2,3-d]pyrimidin-9(8H)-yl]-4-methylbenzenesulfonamide 11b
A mixture of 5a or 5b (1 g, 2.5 mmol) and p-toluene sulphonohydrazide (0.48 g, 2.5 mmol) in dioxane (20 mL) was heated under reflux for 4 h. The formed solid while refluxing in each case was filtered off, dried, and crystallized from dioxane to give 11a and 11b, respectively.
11a: white crystals, yield: 60%, m.p. 279–280 °C. IR (KBr, cm−1): 3444, 3233 (2NH), 1648 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 2.13 (s, 3H, CH3), 5.64 (s, 1H, C4-pyran), 6.85–6.87 (m, 2H, Ar–H), 7.00–7.03 (m, 1H, Ar–H), 7.20–7.48 (m, 6H, Ar–H), 7.59–7.61 (m, 3H, Ar–H), 7.76–7.86 (m, 3H, 1 Ar–H + 2NH exchangeable with D2O), 8.21–8.23 (m, 1H, Ar–H), 8.63 (s, 1H, pyrimidine-H). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 20.91, 38.38, 95.06, 114.79, 120.60, 122.54, 125.12, 125.43, 125.68, 127.35, 127.40, 127.86, 128.07, 128.89, 129.65, 131.34, 132.44, 132.69, 133.00, 137.34, 140.16, 140.48, 143.22, 153.15, 154.88, 159.38. MS (m/z, %): 531 (M + . + 2, 8.71%), 529 (M + ., 26.58%), 432 (50.86%), 312 (30.76%), 192 (69.75%), 82 (52.39%), 76 (100%), 65 (44.12%). Anal. Calc. for C28H21ClN4O3S (529.01): C, 63.57; H, 4.00; Cl, 6.70; N, 10.59; S, 6.06. Found: C, 63.37; H, 3.92; Cl, 6.84; N, 10.50; S, 6.18.
11b: white crystals, yield: 83%, m.p. 280–282 °C. IR (KBr, cm-1): 3443 (NH), 1651(C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 2.20 (s, 3H, CH3), 5.41 (s, 1H, C4-pyran), 6.89 (d, 1H, Ar–H, J = 8.1 Hz), 7.21–7.35 (m, 8H, Ar–H), 7.57–7.70 (m, 3H, Ar–H), 7.91 (d, 1H, Ar–H, J = 7.8 Hz), 8.06 (br.s, 2H, 2NH exchangeable with D2O), 8.25 (d, 1H, Ar–H, J = 7.8 Hz), 8.62 (s, 1H, pyrimidine-H). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 20.76, 37.65, 96.66, 117.63, 120.46, 122.89, 125.46, 125.82, 127.17, 127.35, 127.82, 128.72, 128.80, 129.39, 131.98, 132.82, 140.13, 140.77, 141.25, 142.68, 152.99, 154.91, 158.90. MS (m/z, %): 531 (M + . + 2, 13.14%), 529 (M + ., 57.35%), 510 (87.64%), 417 (100%), 376 (63.78%), 237 (56.82%), 131 (48.89%). Anal. Calc. for C28H21ClN4O3S (529.01): C, 63.57; H, 4.00; Cl, 6.70; N, 10.59; S, 6.06. Found: C, 63.44; H, 4.05; Cl, 6.79; N, 10.51; S, 6.20.
14-(4-Chlorophenyl)-2-phenyl-14H-benzo[7,8]chromeno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine 12
A mixture of imnioether 5b (1 g, 2.5 mmol) and benzoylhydrazide (0.34 g, 2.5 mmol) in dioxane (15 mL) was heated under reflux for 15 h. The reaction mixture was cooled and then poured onto ice-cold water. The obtained solid was filtrated off and crystallized from dioxane to give 12 as pale-yellow crystals; yield: 65%, m.p: 296–297 °C. IR (KBr, cm−1): 3046 (CH-Ar), 1619 (C = N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 5.98 (s, 1H, C4-pyran), 7.30–7.74 (m, 12H, Ar–H), 7.94 (d, 1H, Ar–H, J = 7.5 Hz), 8.16–8.17 (m, 1H, Ar–H), 8.36 (d, 1H, Ar–H, J = 8.1 Hz), 9.69 (s, 1H, pyrimidine-H). MS (m/z, %): 462 (M+. + 2, 6.48%), 460 (M+., 10.95%), 361 (58.62%), 321 (52.46%), 298 (86.61%), 40 (100%). Anal. Calc. for C28H17ClN4O (460.92): C, 72.96; H, 3.72; Cl, 7.69; N, 12.16. Found: C, 73.00; H, 3.82; Cl, 7.60; N, 12.21.
2-{14-(2-Chlorophenyl)-14H-benzo[7,8]chromeno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-2-yl}acetonitrile 13
A mixture of imnioether derivative 5a (1 g, 2.5 mmol) and cyanoacetohydrazide (0.25 g, 2.5 mmol) in dioxane (20 mL) was heated at reflux for 20 h. The reaction mixture was concentrated and allowed to cool. The residue was poured onto ice-cold water and the formed solid was filtered off, dried, and then crystallized from ethanol to give 13 as yellow crystals, yield: 62%, m.p. 156–159 °C. IR (KBr, cm−1): 3340 (NH), 2261, 2192 (C≡N), 1658 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 3.58 (s, 2H, CH2CN), 4.39 (s, 1H, NH, exchangeable with D2O), 5.40 (s, 1H, C4-pyran), 6.27 (s, 1H, = CH), 6.98–8.23 (m, 10H, Ar–H), 9.73 (s, 1H, pyrimidine-H). MS (m/z, %): 425 (M+. + 2, 15.85%), 423 (M+., 4.17%), 413 (63.26%), 375 (41.30%), 303 (48.44%), 179 (70.39%), 75 (30.43%), 62 (100%). Anal. Calc. for C24H14ClN5O (423.86): C, 68.01; H, 3.33; Cl, 8.36; N, 16.52. Found: C, 68.09; H, 3.37; Cl, 8.26; N, 16.48.
2-{14-(2-Chlorophenyl)-14H-benzo[7,8]chromeno[3,2-e][1,2,4]-triazolo[1,5-c]pyrimidin-2-y}-3-(4-methoxyphenyl) acrylonitrile 14
A mixture of 13 (1 g, 2.3 mmol) and p-methoxybenzaldehyde (0.28 mL, 2.3 mmol) in dioxane (15 mL) containing drops of piperidine was refluxed for 9 h. The formed solid while heating was filtered off, dried, and then crystallized from dioxane/DMF (2:1) to give 14 as yellow crystals, yield: 52%, m.p. > 300 °C. IR (KBr, cm−1): 2221 (C≡N), 1626 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 3.83 (s, 3H, OCH3), 6.24 (s, 1H, C4-pyran), 7.08–7.93 (m, 13H, Ar–H), 8.15 (s, 1H, C = CH), 8.30 (d, 1H, Ar–H, J = 7.8 Hz), 9.69 (s, 1H, pyrimidine-H). MS (m/z, %): 544 (M+. + 2, 17.55%), 542 (M+., 27.25%), 514 (40.57%), 497 (30.49%), 464 (34.08%), 441 (100%), 397 (31.98%), 252 (54.39%), 141 (40.41%), 134 (74.54%), 107 (65.92%). Anal. Calc. for C32H20ClN5O2 (542): C, 70.91; H, 3.72; Cl, 6.54; N, 12.92. Found: C, 70.77; H, 3.76; Cl, 6.45; N, 12.97.
3-[14-(2-Chlorophenyl)-14H-benzo[7,8]chromeno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-2-yl]-2H-chromen-2-one 15
A mixture of 13 (1 g, 2.3 mmol) and salicylaldehyde (0.24 mL, 2.3 mmol) in dioxane (20 mL) containing drops of piperidine was refluxed for 5 h. The formed solid while heating was filtered off, dried, and then crystallized from dioxane/DMF (2:1) to give 15 as pale-yellow crystals, yield: 53%, m.p. > 300 °C. IR (KBr, cm-−1): 1747 (CO), 1644 (C=N). 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 6.32 (s, 1H, C4-pyran), 7.01–8.34 (m, 14H, Ar–H), 8.31 (d, 1H, Ar–H), 8.63 (s, 1H, chromenone ring), 9.77 (s, 1H, pyrimidine-H). MS (m/z, %): 530 (M+. + 2, 18.60%), 528 (M+., 31.89%), 496 (40.38%), 386 (48.11%), 257 (37.17%), 96 (90.02%), 129 (46.64%), 59 (100%). Anal. Calc. for C31H17ClN4O3 (528.95): C, 70.39; H, 3.24; Cl, 6.70; N, 10.59. Found: C, 70.54; H, 3.31; Cl, 6.81; N, 10.55.
14-(2-Chlorophenyl)-N-(2-hydroxyphenyl)-14H-benzo[7,8]chromeno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-2-carbohydrazonoyl cyanide 16
To o-amino phenol (1.1 g, 10 mmol), concentrated HCl (3 mL) was added and cooled to ~ 0–5 °C in an ice bath then cooled sodium nitrite solution (1.0 g in 10 mL of water) was added to the mixture dropwise during 10 min. The reaction mixture was then stirred for 10 min. A cold mixture of the acetonitrile derivative 13 (4.35 g, 10 mmol) and sodium acetate (4.10 g, 50 mmol) in ethanol (50 mL), was then added dropwise to the reaction mixture with stirring. The stirring was continued for 30 min, and the reaction mixture was left for 1 h at room temperature. The solid product obtained was collected by filtration and crystallized from ethanol to give 16 as reddish-brown crystals, yield: 61%, m.p: 182–183 oC. IR (KBr, cm-1): br. 3427 (OH, NH), 2258 (C≡N), 1625 (C = N). 1H- NMR (300 MHz, DMSO-d6) δ (ppm): 3.42 (br s, 2H, NH + OH, exchangeable with D2O), 6.11(s, 1H, C4-pyran), 7.14–7.64 (m, 12H, Ar–H), 7.83 (d, 1H, Ar–H, J = 7.8 Hz), 8.26 (d, 1H, Ar–H, J = 8.1 Hz), 9.67 (s, 1H, pyrimidine-H). 13C-NMR (300 MHz, DMSO-d6) δ (ppm): 37.18, 116.05, 116.38, 120.55, 122.86, 124.67, 125.20, 126.99, 127.63, 127.78, 128.95, 129.80, 131.66, 131.90, 132.85, 140.53, 141.02, 143.34, 152.81, 154.34, 160.90. MS (m/z, %): 545 (M+. + 2, 14.13%), 543 (M+., 18.93%), 422 (58.61%), 360 (73.98%), 335 (76.45%), 258 (50.47%), 264 (55.33%), 234 (100%), 215 (47.95%), 155 (68.82%), 122 (34.45%), 68 (42.01%), 41 (78.09%). Anal. Calc. for C30H18ClN7O2 (543.97): C, 66.24; H, 3.34; Cl, 6.52; N, 18.02. Found: C, 66.32; H, 3.46; Cl, 6.43; N, 18.16.
Biological evaluation
Mosquito larval colony
The laboratory strain of C. pipiens was raised and maintained for roughly 24 generations in an insectary at the Entomology Department of the Faculty of Science, Ain Shams University, using the recommended techniques, under controlled conditions at 27 ± 2 °C and RH 75%, and photoperiod 12:12 light: dark hours57. TetraMin was administered to the newly hatched larvae. The pupae were placed within the (25 × 30 × 25) cm wooden cages before being moved. Adults received a 10% sucrose solution every day. The females were permitted to consume a meal of blood provided by a pigeon host58.
Biological assay
The World Health Organization's recommended larval bioassay test protocol was followed for conducting the experiments in a lab setting59. Twenty third-instar C. pipiens larvae were given a variety of insecticidal concentrations of the investigated chemicals ranging from 100 mg/L to 1000 mg/L. Before being diluted with water, the investigated substances were solubilized in dimethylformamide (DMF). Three replicates were used for each concentration, while DMF with water served as the control. The finding of larval mortality was noted after 12 h. Larvae were assumed to be dead if they did not react to touching53. A conventional insecticide “Chlorpyrifos” was tested also as a reference larvicidal compound under the same conditions used for testing our synthesized compounds.
Statistical analysis
The data on larval mortality were examined using the LDP line program's statistical capabilities. The lethal concentrations (LC25, LC50, LC90) were calculated using a 95% confidence interval (C.I.). Additionally, the Abbott formula was employed to account for control mortality, along with the Finney formula, the Chi-square test, and the goodness of fit test (r2)60,61. The toxicity index (T.I) of the investigated chemicals against mosquito larvae is then evaluated using the Sun equation62 which is applied as follows:
Neural receptors 3D structure preparations
The amino acid sequences for the target receptors of the house mosquito (C. pipiens): acetylcholinesterase (AChE) (Accession Number: Q86GC8), nicotinic acetylcholine receptor (nAChR) (Accession Number: A0A8D8NUM7), and voltage-gated sodium channel alpha subunit (VGSC α subunit) (Accession Number: A0A8D8AMN4), were obtained from the UniProt Knowledgebase (UniProtKB) (https://www.uniprot.org/).
Due to the potential limitations of using pre-existing structures, homology modeling was employed to generate 3D models for the AChE enzyme, the nAChR, and the VGSC α subunit binding proteins. SWISS-MODEL (https://swissmodel.expasy.org/), a web-based server for protein structure prediction, was used for this purpose48,63. This server utilizes a combination of BLASTp and HHBlits algorithms to identify suitable template structures within the Protein Data Bank (PDB) and SWISS-MODEL Template Library (SMTL) databases for each receptor48. The identified templates are then used to build a reliable model for the target protein sequence.
The quality of the generated homology models was evaluated using the Z-scoring functions, General Model Quality Estimate (GMQE), and Qualitative Model Energy Analysis (QMEAN), which are specifically designed for SWISS-MODEL outputs28,48,63. These scores provide an objective assessment of the model's accuracy and reliability.
Molecular docking assessment
A molecular docking simulation was performed to understand the potential mode of action underlying the larvicidal activity of the tested compounds. The 2D structures of the fifteen compounds were drawn using ChemDraw 20.0 (CambridgeSoft). The Molecular Operating Environment (MOE V. 2014.02 software; https://www.chemcomp.com/en/index.htm) was then employed for 3D structure generation of the compounds, protonation state assignment, partial charge calculation, and energy minimization. Geometry optimization and energy minimization of the 3D structures were further performed using Wave Function Spartan v 14.0 (Wavefunction Inc., Irvine, CA, USA) to improve docking accuracy26.
The 3D structures of the target receptors (AChE,nAChRs, and VGSC α subunit) were prepared and used as receptors28. The MOE-Site-Finder function was used to define the active site for docking with alpha spheres. A non-bonded cut-off value of 8–10 Å was applied to the Lennard–Jones terms. The energy of the complex was minimized using the MMFF94x force field until the root-mean-square (RMS) gradient reached 0.1 kcal/mol/Å. For each compound-receptor pair, 100 docking poses were generated. The ten poses with the lowest docking energies for each molecule were selected for further analysis. The London ΔG energy scoring function was employed to rank and evaluate the binding affinity of each ligand-receptor complex.
MOE software was used for cross-docking of three reference insecticides: Chlorpyrifos (AChE inhibitor), Nitenpyram (nAChRs agonist), and Indoxacarb (VGSC α subunit blocker) at the alpha pockets of these receptors. The fifteen synthesized compounds were also docked against the same three receptor pockets. Docking scores of the synthesized compounds were compared to the corresponding reference insecticide for each receptor.
Ethics declaration
This study was approved by the Research Ethics Committee at Ain Shams University (Approval code: ASU-SCI/ENTO/2024/1/4) and was performed in accordance with the guidelines of the National Institute of Health (NIH). All methods are reported in accordance with ARRIVE guidelines.
Conclusion
A novel series of substituted benzochromene, benzochromenopyrimidine, and benzochromenotriazolopyrimidine derivatives were designed and synthesized. Their chemical structures were confirmed using various spectroscopic techniques. Fifteen of these compounds were tested for larvicidal activity against C. pipiens larvae and all exhibited significant insecticidal activity compared to the conventional insecticide Chlorpyrifos. Molecular docking studies were performed to elucidate the mechanisms behind the observed larval mortality, and the results suggested that many of the synthesized compounds act as potential insect nerve poisons. Specifically, they were identified as potential acetylcholine esterase inhibitors, which can disrupt the normal nerve physiology of mosquitoes by inhibiting this enzyme, ultimately leading to insect death. These findings offer a promising avenue for combating the insecticidal resistance developed by disease vector mosquitoes against a wide range of conventional insecticides. However, further in vitro and in vivo investigations are necessary to validate these results and to assess the potential impact of these compounds on higher vertebrates.
Supplementary Information
Author contributions
Mahmoud K.F. El-Sayeda, Manal M. Elshahawia, Fatma S.M. Abu El-Azma and Yasmeen M. Ali, synthesised and disscused a new Benzo[h]chromenes derivatives and wrote the main manuscript .Eslam M. Hosny and Mahmoud Kamal carried out the Molecular Modelling and Evaluation of Larvicidal Efficacy of Annulated Benzo[h]chromenes against Culex pipiens L. Larvae and prepared s.file. All authors reviewed the manuscript.
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Data availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-024-68035-0.
References
- 1.Slobbe, P., Ruijter, E. & Orru, R. V. A. Recent applications of multicomponent reactions in medicinal chemistry. Medchemcomm3, 1189–1218. 10.1039/C2MD20089A (2012). 10.1039/C2MD20089A [DOI] [Google Scholar]
- 2.Al Harbi, L. M. et al. Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels. J. Enzyme Inhib. Med. Chem.10.1080/14756366.2022.2155814 (2023). 10.1080/14756366.2022.2155814 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Batran, R. Z. et al. Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking. Bioorg. Chem.75, 274–290. 10.1016/J.BIOORG.2017.09.017 (2017). 10.1016/J.BIOORG.2017.09.017 [DOI] [PubMed] [Google Scholar]
- 4.Lasemi, Z., Azimi, R. & Azizi Amiri, M. Efficient synthesis of 9,10-dihydropyrano[2,3-h]chromene-2,8-dione derivatives in ionic liquid and the study of their antioxidant activity. Nat. Prod. Res.31, 1–6. 10.1080/14786419.2016.1166493 (2017). 10.1080/14786419.2016.1166493 [DOI] [PubMed] [Google Scholar]
- 5.Rajanarendar, E. et al. Design, synthesis, antimicrobial, anti-inflammatory and analgesic activity of novel isoxazolyl pyrimido[4,5-b]quinolines and isoxazolyl chromeno[2,3-d]pyrimidin-4-ones. Eur. J. Med. Chem.55, 273–283. 10.1016/J.EJMECH.2012.07.029 (2012). 10.1016/J.EJMECH.2012.07.029 [DOI] [PubMed] [Google Scholar]
- 6.Gupta, S. et al. Synthesis and bio-evaluation of indole-chalcone based benzopyrans as promising antiligase and antiproliferative agents. Eur. J. Med. Chem.143, 1981–1996. 10.1016/J.EJMECH.2017.11.015 (2018). 10.1016/J.EJMECH.2017.11.015 [DOI] [PubMed] [Google Scholar]
- 7.Termentzi, A. et al. Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring. Eur. J. Med. Chem.45, 5833–5847. 10.1016/J.EJMECH.2010.09.048 (2010). 10.1016/J.EJMECH.2010.09.048 [DOI] [PubMed] [Google Scholar]
- 8.Vala, N. D., Jardosh, H. H. & Patel, M. P. PS-TBD triggered general protocol for the synthesis of 4H-chromene, pyrano[4,3-b]pyran and pyrano[3,2-c]chromene derivatives of 1H-pyrazole and their biological activities. Chin. Chem. Lett.27, 168–172. 10.1016/J.CCLET.2015.09.020 (2016). 10.1016/J.CCLET.2015.09.020 [DOI] [Google Scholar]
- 9.Abd El-Mawgoud, H. K., Radwan, H. A. M., El-Mariah, F. & El-Agrody, A. M. Synthesis, characterization, biological activity of novel 1H-benzo[f]- chromene and 12H-benzo[f]chromeno[2,3-d]pyrimidine derivatives. Lett. Drug Des. Discov.15, 857–865. 10.2174/1570180814666171027160854 (2017). 10.2174/1570180814666171027160854 [DOI] [Google Scholar]
- 10.Ameli, S., Pordel, M., Davoodnia, A. & Jajarmi, M. Synthesis and antibacterial activity of some new benzo[5,6]chromeno[2,3-d]pyrimidines. Russ. J. Bioorg. Chem.43, 429–434. 10.1134/S1068162017040100/METRICS (2017). 10.1134/S1068162017040100/METRICS [DOI] [Google Scholar]
- 11.Abu El-Azm, F. S. M., El-Shahawi, M. M., Elgubbi, A. S. & Madkour, H. M. F. Design, synthesis, anti-proliferative activity, and molecular docking studies of novel benzo[f]chromene, chromeno [2,3-d]pyrimidines and chromenotriazolo[1,5-c]pyrimidines. Synth. Commun.50, 669–683. 10.1080/00397911.2019.1710850 (2020). 10.1080/00397911.2019.1710850 [DOI] [Google Scholar]
- 12.Abu El-Azm, F. S. M., El-Shahawi, M. M., Elgubbi, A. S. & Madkour, H. M. F. Synthesis of new benzo[f]chromene-based heterocycles targeting anti-proliferative activity. J. Iran. Chem. Soc.18, 1081–1092. 10.1007/S13738-020-02092-W/METRICS (2021). 10.1007/S13738-020-02092-W/METRICS [DOI] [Google Scholar]
- 13.Ali, A. T. & Hekal, M. H. Convenient synthesis and anti-proliferative activity of some benzochromenes and chromenotriazolopyrimidines under classical methods and phase transfer catalysis. Synth. Commun.49, 3498–3509. 10.1080/00397911.2019.1675173 (2019). 10.1080/00397911.2019.1675173 [DOI] [Google Scholar]
- 14.Dgachi, Y. et al. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer’s disease. Molecules21, 634. 10.3390/MOLECULES21050634 (2016). 10.3390/MOLECULES21050634 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sashidhara, K. V., Kumar, M., Modukuri, R. K., Srivastava, A. & Puri, A. Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents. Bioorg. Med. Chem. Lett.21, 6709–6713. 10.1016/J.BMCL.2011.09.053 (2011). 10.1016/J.BMCL.2011.09.053 [DOI] [PubMed] [Google Scholar]
- 16.El-Sayed, W. A., Mohamed, A. M., Khalaf, H. S., El-Kady, D. S. & Al-Manawaty, M. Synthesis, docking studies and anticancer activity of new substituted pyrimidine and triazolopyrimidine glycosides. J. Appl. Pharm. Sci.7, 001–011. 10.7324/JAPS.2017.70901 (2017). 10.7324/JAPS.2017.70901 [DOI] [Google Scholar]
- 17.Hassan, G. S. et al. Synthesis and antitumor testing of certain new fused triazolopyrimidine and triazoloquinazoline derivatives. Arab. J. Chem.10, S1345–S1355. 10.1016/J.ARABJC.2013.04.002 (2017). 10.1016/J.ARABJC.2013.04.002 [DOI] [Google Scholar]
- 18.El-Sayed, W. A., Abbas, H. A. S., Abdel Mageid, R. E. & Magdziarz, T. Synthesis, antimicrobial activity and docking studies of new N-ethyl-3-indolyl heterocycles. Med. Chem. Res.25, 339–355. 10.1007/S00044-015-1488-4/METRICS (2016). 10.1007/S00044-015-1488-4/METRICS [DOI] [Google Scholar]
- 19.Yoo, S. J., Kim, H. O., Lim, Y., Kim, J. & Jeong, L. S. Synthesis of novel (2R,4R)- and (2S,4S)-iso dideoxynucleosides with exocyclic methylene as potential antiviral agents. Bioorg. Med. Chem.10, 215–226. 10.1016/S0968-0896(01)00266-8 (2002). 10.1016/S0968-0896(01)00266-8 [DOI] [PubMed] [Google Scholar]
- 20.Gorris, M. E. et al. Updated distribution maps of predominant Culex mosquitoes across the Americas. Parasit. Vectors14, 1–13. 10.1186/S13071-021-05051-3/TABLES/2 (2021). 10.1186/S13071-021-05051-3/TABLES/2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Barba, M., Fairbanks, E. L. & Daly, J. M. Equine viral encephalitis: Prevalence, impact, and management strategies. Vet. Med. Res. Rep.10.2147/VMRR.S168227 (2019). 10.2147/VMRR.S168227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Vitek, C. J., Richards, S. L., Mores, C. N., Day, J. F. & Lord, C. C. Arbovirus transmission by Culex nigripalpus in Florida, 2005. J. Med. Entomol.45, 483. 10.1603/0022-2585(2008)45[483:atbcni]2.0.co;2 (2008). 10.1603/0022-2585(2008)45[483:atbcni]2.0.co;2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hamer, G. L. et al. Host selection by Culex pipiens mosquitoes and west nile virus amplification. Am. J. Trop. Med. Hyg.80, 268–278. 10.4269/AJTMH.2009.80.268 (2009). 10.4269/AJTMH.2009.80.268 [DOI] [PubMed] [Google Scholar]
- 24.Adly, E., Hegazy, A. A., Kamal, M. & Abu-Hussien, S. H. Midguts of Culexpipiens L. (Diptera: Culicidae) as a potential source of raw milk contamination with pathogens. Sci. Rep.12, 13183. 10.1038/s41598-022-16992-9 (2022). 10.1038/s41598-022-16992-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sato, Y. et al. Insecticide resistance by a host-symbiont reciprocal detoxification. Nat. Commun.12(1), 1–8. 10.1038/s41467-021-26649-2 (2021). 10.1038/s41467-021-26649-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.El-Sayed, M. K. F., El-Shahawi, M. M., Ali, Y. M., Abdel-Haleem, D. R. & Abu El-Azm, F. S. M. Synthesis, larvicidal efficiency and molecular docking studies of novel annulated pyrano[2,3-c]pyrazoles against Culexpipiens L. and Muscadomestica L. larvae. Bioorg. Chem.130, 106258. 10.1016/j.bioorg.2022.106258 (2023). 10.1016/j.bioorg.2022.106258 [DOI] [PubMed] [Google Scholar]
- 27.Gupta, R. C. & Milatovic, D. Insecticides, Biomarkers in Toxicology 389–407 (Elsevier, 2014). 10.1016/B978-0-12-404630-6.00023-3. [Google Scholar]
- 28.Rao, P., Goswami, D. & Rawal, R. M. Revealing the molecular interplay of curcumin as Culex pipiens Acetylcholine esterase 1 (AChE1) inhibitor. Sci. Rep.10.1038/s41598-021-96963-8 (2021). 10.1038/s41598-021-96963-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Imramovsky, A. et al. Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking. Molecules17, 10142–10158. 10.3390/MOLECULES170910142 (2012). 10.3390/MOLECULES170910142 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ihara, M. et al. Crystal structures of Lymnaea stagnalis AChBP in complex with neonicotinoid insecticides imidacloprid and clothianidin. Invertebr. Neurosci.8, 71–81. 10.1007/S10158-008-0069-3/FIGURES/5 (2008). 10.1007/S10158-008-0069-3/FIGURES/5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Duan, H. et al. A novel halogen bond and a better-known hydrogen bond cooperation of neonicotinoid and insect nicotinic acetylcholine receptor recognition. J. Mol. Model18, 3867–3875. 10.1007/S00894-012-1393-4/FIGURES/5 (2012). 10.1007/S00894-012-1393-4/FIGURES/5 [DOI] [PubMed] [Google Scholar]
- 32.Lapied, B., Grolleau, F. & Sattelle, D. B. Indoxacarb, an oxadiazine insecticide, blocks insect neuronal sodium channels. Br. J. Pharmacol.132, 587. 10.1038/SJ.BJP.0703853 (2001). 10.1038/SJ.BJP.0703853 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hekal, M. H., Samir, S. S., Ali, Y. M. & El-Sayed, W. M. New Benzochromeno[2,3-d]Pyrimidines and Benzochromenotriazolo[1,5-c]Pyrimidines as potential inhibitors of topoisomerase II. Polycycl. Aromat. Compd.42, 7644–7660. 10.1080/10406638.2021.2006247 (2022). 10.1080/10406638.2021.2006247 [DOI] [Google Scholar]
- 34.Hekal, M. H., Ali, Y. M., Abdel- Haleem, D. R. & Abu El-Azm, F. S. M. Diversity oriented synthesis and SAR studies of new quinazolinones and related compounds as insecticidal agents against Culexpipiens L. Larvae and associated predator. Bioorg. Chem.133, 106436. 10.1016/J.BIOORG.2023.106436 (2023). 10.1016/J.BIOORG.2023.106436 [DOI] [PubMed] [Google Scholar]
- 35.Hekal, M. H., Ali, Y. M. & Abu El-Azm, F. S. M. Utilization of cyanoacetohydrazide and 2-(1,3-Dioxoisoindolin-2-yl) acetyl chloride in the synthesis of some novel anti-proliferative heterocyclic compounds. Synth. Commun.50, 2839–2852. 10.1080/00397911.2020.1786125 (2020). 10.1080/00397911.2020.1786125 [DOI] [Google Scholar]
- 36.Hekal, M. H., Abu El-Azm, F. S. M. & Sallam, H. A. Synthesis, spectral characterization, and in vitro biological evaluation of some novel isoquinolinone-based heterocycles as potential antitumor agents. J. Heterocyclic Chem.56, 795–803. 10.1002/jhet.3448 (2019). 10.1002/jhet.3448 [DOI] [Google Scholar]
- 37.Mahmoud, M. R., Abu El-Azm, F. S. M., Ali, A. T. & Ali, Y. M. Synthesis and antimicrobial evaluation of some novel dithiolane, thiophene, coumarin, and 2-pyridone derivatives. Synth. Commun.47, 1591–1600. 10.1080/00397911.2017.1336776 (2017). 10.1080/00397911.2017.1336776 [DOI] [Google Scholar]
- 38.Ali, Y. M., Ismail, M. F., Abu El-Azm, F. S. M. & Marzouk, M. I. Design, synthesis, and pharmacological assay of novel compounds based on pyridazine moiety as potential antitumor agents. J. Het. Chem.56, 2580–2591. 10.1002/jhet.3662 (2019). 10.1002/jhet.3662 [DOI] [Google Scholar]
- 39.Maleki, B., Baghayeri, M., Sheikh, S., Babaee, S. & Farhadi, S. One-pot synthesis of some 2-amino-4H-chromene derivatives using triethanolamine as a novel reusable organocatalyst under solvent-free conditions and its application in electrosynthesis of silver nanoparticles. Russ. J. Gen. Chem.87, 1064–1072. 10.1134/S1070363217050280/METRICS (2017). 10.1134/S1070363217050280/METRICS [DOI] [Google Scholar]
- 40.Kumar, D. et al. Nanosized magnesium oxide as catalyst for the rapid and green synthesis of substituted 2-amino-2-chromenes. Tetrahedron63, 3093–3097. 10.1016/J.TET.2007.02.019 (2007). 10.1016/J.TET.2007.02.019 [DOI] [Google Scholar]
- 41.Eissa, I. H., El-Naggar, A. M. & El-Hashash, M. A. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents. Bioorg. Chem.67, 43–56. 10.1016/j.bioorg.2016.05.006 (2016). 10.1016/j.bioorg.2016.05.006 [DOI] [PubMed] [Google Scholar]
- 42.Abd El-Wahab, A. H. Synthesis, reactions and evaluation of the antimicrobial activity of some 4-(p-Halophenyl)-4H-naphthopyran. Pyranopyrimidine Pyranotriazolopyrimidine Deriv. Pharm.5, 745–757. 10.3390/ph5070745 (2012). 10.3390/ph5070745 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hazrathoseyni, A. et al. Synthesis, characterization, and docking evaluations of new derivatives of pyrimido[4,5-c]pyridazine as potential human AKT1 inhibitors. J. Heterocycl. Chem.53, 135–143. 10.1002/JHET.2296 (2016). 10.1002/JHET.2296 [DOI] [Google Scholar]
- 44.Mahmoud, M. R., Abu El-Azm, F. S. M., Ali, A. T. & Ali, Y. M. Design, synthesis, and antimicrobial evaluation of novel thienopyrimidines and triazolothienopyrimidines. Synth. Commun.45, 982–992. 10.1080/00397911.2014.999340 (2015). 10.1080/00397911.2014.999340 [DOI] [Google Scholar]
- 45.Fouad, S. A. Synthesis, characterization and anti-breast cancer activity of some new pyrazole, thiazole, chromene and pyridine derivatives. Int. J. Adv. Res. (Indore)2, 442–453 (2014). [Google Scholar]
- 46.Hamed, N. A., Marzouk, M. I., Ismail, M. F. & Hekal, M. H. N’-(1-([1,1’-biphenyl]-4-yl)ethylidene)-2-cyanoacetohydrazide as scaffold for the synthesis of diverse heterocyclic compounds as prospective antitumor and antimicrobial activities. Synth. Commun.49, 3017–3029. 10.1080/00397911.2019.1655578 (2019). 10.1080/00397911.2019.1655578 [DOI] [Google Scholar]
- 47.M.R. Mahmoud, M.M. El-Shahawi, F.S.M. Abu El-Azm, M. Abdeen, Synthesis and Antimicrobial Activity of Polyfunctionally Substituted Heterocyclic Compounds Derived from 5-Cinnamoylamino-2-Cyanomethyl-1,3,4-Thiadiazole, J Heterocycl Chem 54 (2017) 2352–2359. 10.1002/JHET.2824.
- 48.Waterhouse, A. et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res.46, W296–W303. 10.1093/nar/gky427 (2018). 10.1093/nar/gky427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Insecticides: Chemistries and Characteristics - e, (n.d.). https://studylib.net/doc/7378532/insecticides--chemistries-and-characteristics---e (Accessed 8 April 2024).
- 50.Metcalf, R. Structure-Activity Relationships for Insecticidal Carbamates (Bull World Health Organ, 1971). [PMC free article] [PubMed] [Google Scholar]
- 51.Sakka, M. K., Ioannou, C. S., Papadopoulos, N. T. & Athanassiou, C. G. Residual efficacy of selected larvicides against Culex pipiens pipiens (Diptera: Culicidae) under laboratory and semi-field conditions. Environ. Sci. Pollut. Res.30, 40931–40941. 10.1007/S11356-022-24654-6/FIGURES/5 (2023). 10.1007/S11356-022-24654-6/FIGURES/5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ali, K. A. et al. Synthesis, anticancer screening and molecular docking studies of new heterocycles with trimethoxyphenyl scaffold as combretastatin analogues. Mini Rev. Med. Chem.18, 1–1. 10.2174/1389557517666170425104241 (2018). 10.2174/1389557517666170425104241 [DOI] [PubMed] [Google Scholar]
- 53.Ismail, M. F., El-Sayed, A. A., Hosni, E. M. & Hassaballah, A. I. Synthesis and evaluation of larvicidal efficacy against C. pipiens of some new heterocyclic compounds emanated from 2-cyano-N’-(2-(2,4-dichlorophenoxy)acetyl)acetohydrazide. Chem. Biodivers.10.1002/CBDV.202301560 (2024). 10.1002/CBDV.202301560 [DOI] [PubMed] [Google Scholar]
- 54.Xu, Y., Cheng, S., Sussman, J. L., Silman, I. & Jiang, H. Computational studies on acetylcholinesterases. Molecules22, 1324. 10.3390/MOLECULES22081324 (2017). 10.3390/MOLECULES22081324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Prieto-Martínez, F. D. et al. Molecular docking: Current advances and challenges, TIP. Revista Especializada En Ciencias Químico-Biológicas21, 65–87. 10.22201/FESZ.23958723E.2018.0.143 (2018). 10.22201/FESZ.23958723E.2018.0.143 [DOI] [Google Scholar]
- 56.Santos, L. H. et al. Understanding structure-activity relationships for trypanosomal cysteine protease inhibitors by simulations and free energy calculations. J. Chem. Inf. Model.59, 137–148. 10.1021/ACS.JCIM.8B00557/SUPPL_FILE/CI8B00557_SI_001.PDF (2019). 10.1021/ACS.JCIM.8B00557/SUPPL_FILE/CI8B00557_SI_001.PDF [DOI] [PubMed] [Google Scholar]
- 57.Shah, R. M. et al. Toxicity of 25 synthetic insecticides to the field population of Culex quinquefasciatus Say. Parasitol. Res.115, 4345–4351. 10.1007/S00436-016-5218-8 (2016). 10.1007/S00436-016-5218-8 [DOI] [PubMed] [Google Scholar]
- 58.Kauffman, E. et al. Rearing of Culex spp. and Aedes spp, mosquitoes. Bio-Protocol.7, 2542. 10.21769/BioProtoc.2542 (2017). 10.21769/BioProtoc.2542 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.World Health Organization, Guidelines for laboratory and field testing of mosquito larvicides. https://apps.who.int/iris/handle/10665/69101 (2005).
- 60.Abbott, W. S. A method of computing the effectiveness of an insecticide. J. Econ Entomol.18, 265–267. 10.1093/JEE/18.2.265A (1925). 10.1093/JEE/18.2.265A [DOI] [Google Scholar]
- 61.Probit Analysis, 3rd ed. By D. J. Finney, Cambridge University Press, 32 E. 57th St., New York, Ny 10022, 1971. xv + 333 pp. 14.5 × 22 cm. Price $18.50. J. Pharm. Sci. 60, 1432–1432. 10.1002/JPS.2600600940 (1971).
- 62.Sun, Y.-P. Toxicity index-an improved method of comparing the relative toxicity of insecticides1. J. Econ. Entomol.43, 45–53. 10.1093/JEE/43.1.45 (1950). 10.1093/JEE/43.1.45 [DOI] [Google Scholar]
- 63.Bateman, A. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res.47, D506–D515. 10.1093/nar/gky1049 (2019). 10.1093/nar/gky1049 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this published article and its supplementary information files.








